Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has received IND clearance from the U.S. Food and Drug Administration (FDA ...

The Institute of Internal Auditors has released its latest "topical requirement," this time on organizational behavior as ...

Delhi State, successfully hosted the IIA Udyog Samman 2025 at the JNU Convention Centre, Auditorium 1, New Delhi, marking a ...

Karnataka High Court sentences former IIA employee to four months in prison for contempt of court in two cases.

The Institute of Internal Auditors today released the Organizational Behavior Topical Requirement, the third in a series of Topical Requirements and the final to be published in 2025. Incorporating ...

Qihan Biotech, a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune diseases and cancer, including allogeneic CAR-T and in vivo CAR-T therapies, today ...

The multinational Phase I/IIa trial is designed to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of CMND-100 in patients with moderate to severe AUD. Dosing for the ...

Lucknow: Varanasi will host the IIA International Tourism and Hospitality Expo 2025 on December 18 and 19 at Hotel Taj Ganges ...

Throughout 2025, Clearmind achieved critical milestones in its FDA-approved Phase I/IIa clinical trial for CMND-100, a proprietary non-hallucinogenic MEAI-based oral compound designed to address AUD—a ...

Mumbai (Maharashtra) [India], December 24: Actor, Entrepreneur, and style icon Shilpa Shetty announces her much awaited signature Mangalsutra Bracelet collection, this time crafted in purest Type IIa ...

The study protocol comprises dose-expansion and dose-escalation phases and aims to assess the efficacy and safety of QT-019B.

Discover the Institute of Internal Auditors' certifications, including CIA and CRMA. Learn about its history, mission, global reach, and benefits for professionals.